Lawrence J Burgart1. 1. Mayo Clinic, Rochester, MN, USA. lawrence.burgart@allina.com
Abstract
CONTEXT: Significant bench and clinical data have been generated during the last decade regarding DNA mismatch repair in colorectal carcinoma. OBJECTIVES: To review clinically relevant aspects of defective DNA mismatch repair in colorectal carcinoma and to suggest testing algorithms for identification of these tumors in the sporadic and familial settings. DATA SOURCES: This article is based on literature review and clinical testing experience of more than 2000 patient samples. CONCLUSIONS: Approximately 15% of colorectal carcinomas arise as a result of defective DNA mismatch repair. Ninety percent of these carcinomas are sporadic, arising as a result of methylation of the MLH1 gene promoter, silencing expression. These sporadic carcinomas have improved stage-specific prognosis and can be identified by demonstrating aberrant loss of expression with an MLH1 immunoperoxidase stain. Familial colorectal carcinomas with defective DNA mismatch repair (Lynch syndrome) are due to a germline defect in one of several DNA mismatch repair genes. The familial carcinomas are best identified with a combination of immunohistochemistry and molecular microsatellite analysis. This testing facilitates subsequent directed genetic testing of the proband and family members.
CONTEXT: Significant bench and clinical data have been generated during the last decade regarding DNA mismatch repair in colorectal carcinoma. OBJECTIVES: To review clinically relevant aspects of defective DNA mismatch repair in colorectal carcinoma and to suggest testing algorithms for identification of these tumors in the sporadic and familial settings. DATA SOURCES: This article is based on literature review and clinical testing experience of more than 2000 patient samples. CONCLUSIONS: Approximately 15% of colorectal carcinomas arise as a result of defective DNA mismatch repair. Ninety percent of these carcinomas are sporadic, arising as a result of methylation of the MLH1 gene promoter, silencing expression. These sporadic carcinomas have improved stage-specific prognosis and can be identified by demonstrating aberrant loss of expression with an MLH1 immunoperoxidase stain. Familial colorectal carcinomas with defective DNA mismatch repair (Lynch syndrome) are due to a germline defect in one of several DNA mismatch repair genes. The familial carcinomas are best identified with a combination of immunohistochemistry and molecular microsatellite analysis. This testing facilitates subsequent directed genetic testing of the proband and family members.
Authors: Aparna Mukherjee; Thomas J McGarrity; Francesca Ruggiero; Walter Koltun; Kevin McKenna; Lisa Poritz; Maria J Baker Journal: Hered Cancer Clin Pract Date: 2010-11-22 Impact factor: 2.857
Authors: Brindusa Truta; Yunn-Yi Chen; Amie M Blanco; Guoren Deng; Peggy G Conrad; Yong Ho Kim; Eun Taek Park; Sanjay Kakar; Young S Kim; Fernando Velayos; Marvin H Sleisenger; Jonathan P Terdiman Journal: Fam Cancer Date: 2008-02-19 Impact factor: 2.375
Authors: M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic Journal: Fam Cancer Date: 2007-04-24 Impact factor: 2.375